Divestiture/carve-outMar 23, 2026Pending
🇺🇸 United States
EPEyeSouth Partners' retina businessCCencora, Inc.
Healthcare › Healthcare Services
Deal valueUndisclosed
AnnouncedMar 23, 2026
ConsiderationUndisclosed
StructureOther
RegionNorth America
Cross-borderNo
Contingent paymentNo
Overview
Cencora entered into a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, with the affiliated retina physicians joining Cencora's Retina Consultants of America MSO.
Deal rationale
The acquisition expands Retina Consultants of America's physician network and is expected to be slightly accretive to Cencora's adjusted diluted EPS in the first twelve months after closing.
AI-generated from the SEC filingPendingHealthcare › Healthcare ServicesUnited StatesNorth America
Timeline
Valuation and terms
| Equity value | Undisclosed | |
|---|---|---|
| Enterprise value | Undisclosed | |
| Consideration | Undisclosed |
Advisors
Buy-side
BOBank of AmericaCCiti
Sell-side
JJefferies
Parties
Target
EPEyeSouth Partners' retina business
- Headquarters
- United States
- Ticker
- —
Seller
EPEyeSouth Partners (portfolio company of Olympus Partners)
- Headquarters
- —
- Ticker
- —